The Telegraph reports the Apple Watch may soon be able to boast measuring of blood pressure, blood glucose, and blood alcohol levels among its features, according to newly-revealed information about one of Apple’s chosen business partners.
The report says Apple is the largest customer of the British electronics start-up Rockley Photonics, which has developed non-invasive optical sensors for detecting multiple blood-related health metrics, including blood pressure, blood glucose, and blood alcohol levels. The company’s sensors beam infrared light through a user’s skin, much like the existing sensors on the back of the Apple Watch for detecting heart rate and blood oxygen levels.
Rockley Photonics disclosure of Apple as its largest client comes as the company prepares to go public. The company’s filings revealed Apple accounted for the majority of its revenue over the last two years. The disclosure also said the firm has an ongoing “supply and development agreement” with Apple.
Rockley has an office in San Jose, along with facilities in Oxford, Cardiff, Cork, and Helsinki. Rockley has said that its next-generation sensors could be in consumer smartwatches and other electronics as soon as next year.
